Press Releases Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-15 pm EDT			5-day change	1st Jan Change
36.51 ^USD	+0.75%		+2.82%	+43.12%

Jun. 30	Royalty Pharma plc(NasdaqGS:RPRX) dropped from Russell 1000 Value-Defensive Index	CI
Jun. 30	Royalty Pharma plc(NasdaqGS:RPRX) dropped from Russell 1000 Defensive Index	CI

Press Releases

Royalty Pharma : Q2 2025 Pre-Quarterly Results Communication	Jun. 27	PU
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion	Jun. 24	GL
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference	Jun. 04	GL
Royalty Pharma : Related Party Transaction Policy pdf	May. 19	PU
Royalty Pharma : Whistleblower Policy pdf	May. 19	PU
Royalty Pharma : Management Development and Compensation Committee pdf	May. 19	PU
Royalty Pharma : Audit Committee pdf	May. 19	PU
Royalty Pharma Completes the Acquisition of Its External Manager	May. 16	GL
Royalty Pharma Completes the Acquisition of Its External Manager	May. 16	AQ
Royalty Pharma to Present at Upcoming Investor Conferences	May. 13	GL
Royalty Pharma to Present at Upcoming Investor Conferences	May. 13	AQ
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition	May. 12	GL
Royalty Pharma: Q1 Earnings Snapshot	May. 08	AQ
Royalty Pharma Reports First Quarter 2025 Results	May. 08	GL
Royalty Pharma Declares Second Quarter 2025 Dividend	Apr. 21	GL
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025	Apr. 17	GL
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025	Apr. 17	AQ
Royalty Pharma : 2024 Corporate Responsibility Report pdf	Apr. 14	PU
Royalty Pharma : U.K. Companies Act Annual Report - 2024	Apr. 11	PU
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors	Apr. 08	GL
Royalty Pharma : Q1 2025 Pre-Quarterly Communication	Apr. 02	PU
Royalty Pharma Announces Upcoming Investor Day	Mar. 27	GL
Royalty Pharma Announces Upcoming Investor Day	Mar. 27	AQ
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License	Mar. 14	AQ
Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference	Feb. 27	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Pharmaceuticals

Press Releases

Filters